Ongoing Symptoms, Formation of Interstitial Lung Disease and Follow-up Process in PostCOVID-19

In December 2019, severe acute respiratory diseases due to syndrome coronavirus-2 (SARS-CoV-2) were reported from Wuhan province of China. The symptoms associated with Coronavirus Disease-2019 (COVID-19) range mild upper tract infection distress (ARDS). It was observed that and radiological findings continued in some patients after discharge. Comorbidities such as hypertension diabetes, risk factors male gender advanced age are common for COVID-19 idiopathic pulmonary fibrosis (IPF). However, the role anti fibrotictherapy scientific rationale their continuation or discontinuation IPF infected SARS-CoV-2 have not been fully defined. Data pandemic previous coronavirus infections (SARS) Middle East (MERS) suggest there may be significant fibrotic changes following infection. this article, frequency on going pneumonia interstitial lung disease ocur discussed. Inaddition, prevention lung, especially fibrosis, decrease functions discussed light literature.